Physician profile
Jay Raman Gavvala
NPI 1427281310
$4,433.87
in general payments reported to CMS, 2019-2025
15 companies · $2,342 in 2025
The $2,342 reported for 2025 was more than what 77% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $93.47 · 2022: $49.77 · 2023: $680 · 2024: $1,137 · 2025: $2,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,417 · Travel and Lodging: $725 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,416.92 |
| Travel and Lodging | $724.75 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $1,161.46 | 2019-2025 | |
| Sk Life Science, INC. | $824.57 | 2023-2025 | Xcopri |
| Ucb, INC. | $775.65 | 2023-2025 | Briviact, Fintepla, Nayzilam |
| Jazz Pharmaceuticals INC. | $719.57 | 2022-2025 | |
| Medtronic, INC. | $428.36 | 2023-2025 | Percept Pc Brainsense, Activa Pc |
| Sumitomo Pharma America, INC. | $150.67 | 2023-2024 | Aptiom |
| Aucta Pharmaceuticals, INC. | $117.20 | 2024-2025 | Motpoly Xr |
| Acadia Pharmaceuticals INC | $79.11 | 2023-2025 | Nuplazid, Daybue |
| Catalyst Pharmaceuticals, INC. | $34.37 | 2024 | |
| Livanova USA, INC. | $32.08 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Neurocrine Biosciences, INC. | $27.72 | 2025 | |
| Otter Pharmaceuticals, LLC | $24.94 | 2024 | Sympazan |
| Abbvie INC. | $23.68 | 2024 | |
| Abbott Laboratories | $17.88 | 2025 | Infinity |
| Eisai INC. | $16.61 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Gavvala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.